ClinicalTrials.Veeva

Menu

Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents

Indiana University logo

Indiana University

Status

Completed

Conditions

Attitude to Health
Influenza Vaccines
Human Papillomavirus Vaccines

Treatments

Behavioral: Provider Communication about Vaccination

Study type

Interventional

Funder types

Other

Identifiers

NCT02358083
8645194

Details and patient eligibility

About

The purpose of this study was to determine whether messages about 1. relative risk of vaccination vs. other activities and 2. strength of doctor's recommendation influenced parental intention to get own child vaccinated against human papillomavirus (HPV) or Influenza.

Enrollment

1,165 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Lives in United States
  • Mother or female legal guardian of at least one child aged 9-13
  • Able to understand English
  • For HPV condition: Target child must not have received any doses of HPV vaccine
  • For Flu condition: Target child must not have received the flu vaccine during the prior flu season

Exclusion criteria

  • Under 18 years of age
  • Not mother or female legal guardian of at least one child ages 9-13
  • Not living in United States
  • Not able to understand English and Spanish
  • For HPV condition: Target child had already received at least 1 dose of the HPV vaccine
  • For Flu condition: Target child received the influenza vaccine during the previous flu season

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

1,165 participants in 12 patient groups

Arm 1. HPV + Control + Control
No Intervention group
Description:
HPV is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
Arm 2. HPV + Control + Strong
Experimental group
Description:
HPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 3. HPV + Control + Disclosure
Experimental group
Description:
HPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 4. HPV + Safety + Control
Experimental group
Description:
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 5. HPV + Safety + Strong
Experimental group
Description:
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 6. HPV + Safety + Disclosure
Experimental group
Description:
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 7. Flu + Control + Control
No Intervention group
Description:
Flu is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
Arm 8. Flu + Control + Strong
Experimental group
Description:
Flu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 9. Flu + Control + Disclosure
Experimental group
Description:
Flu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 10. Flu + Safety + Control
Experimental group
Description:
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 11. Flu + Safety + Strong
Experimental group
Description:
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
Treatment:
Behavioral: Provider Communication about Vaccination
Arm 12. Flu + Safety + Disclosure
Experimental group
Description:
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Treatment:
Behavioral: Provider Communication about Vaccination

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems